Patents by Inventor Andrew A. Shaw

Andrew A. Shaw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EXTENDED-RELEASE DOSAGE FORM
    Publication number: 20170049724
    Abstract: Provided are pharmaceutical formulations comprising sustained release particles each having an inner core bead comprising an active pharmaceutical ingredient an intermediate coating substantially surrounding the inner core bead, and an outer coating substantially surrounding the intermediate coating comprising a pH independent polymer. Also provided is a pharmaceutical formulation comprising two bead populations wherein each of the first and second bead populations have a different drug release profile. Also provided is a method of preparing an extended release dosage composition comprising one or more bead populations.
    Type: Application
    Filed: July 25, 2016
    Publication date: February 23, 2017
    Inventors: Pavan Bhat, Sarat J. Chattaraj, Andrew A. Shaw
  • EXTENDED-RELEASE DOSAGE FORM
    Publication number: 20110123613
    Abstract: Provided are pharmaceutical formulations comprising sustained release particles each having an inner core bead comprising an active pharmaceutical ingredient an intermediate coating substantially surrounding the inner core bead, and an outer coating substantially surrounding the intermediate coating comprising a pH independent polymer. Also provided is a pharmaceutical formulation comprising two bead populations wherein each of the first and second bead populations have a different drug release profile. Also provided is a method of preparing an extended release dosage composition comprising one or more bead populations.
    Type: Application
    Filed: December 23, 2010
    Publication date: May 26, 2011
    Applicant: MYLAN TECHNOLOGIES INC.
    Inventors: Pavan Bhat, Sarat C. Chattaraj, Andrew A. Shaw
  • Treatment of Cardiovascular Disease in Mexican Americans Using Nebivolol
    Publication number: 20090030071
    Abstract: Nebivolol has been shown to be beneficial in the treatment of cardiovascular diseases such as, but not limited to, hypertension, congestive heart failure, arterial stiffness and endothelial dysfunction. The present invention relates to methods for treating and/or preventing cardiovascular disorders in persons of Hispanic descent, particularly Mexican Americans, using compositions comprising nebivolol.
    Type: Application
    Filed: July 15, 2008
    Publication date: January 29, 2009
    Inventors: Andrew A. Shaw, R. Preston Mason, Betty Riggs
  • Extended-release dosage form
    Publication number: 20080187579
    Abstract: Provided are pharmaceutical formulations comprising sustained release particles each having an inner core bead comprising an active pharmaceutical ingredient an intermediate coating substantially surrounding the inner core bead, and an outer coating substantially surrounding the intermediate coating comprising a pH independent polymer. Also provided is a pharmaceutical formulation comprising two bead populations wherein each of the first and second bead populations have a different drug release profile. Also provided is a method of preparing an extended release dosage composition comprising one or more bead populations.
    Type: Application
    Filed: February 1, 2007
    Publication date: August 7, 2008
    Inventors: Pavan Bhat, Sarat C. Chattaraj, Andrew A. Shaw